Pneumococcal induced T-activation with resultant thrombotic microangiopathy

Clinical Medicine Insights: Pathology

Volumn , Issue 3, 2010, Pages 13-17

  Oliver, J W ^a   Akins, R S ^a   Bibens, M K ^a   Dunn, D M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Hemolytic uremic syndrome; HUS; Pneumococcus; Polyagglutination; Streptococcus pneumoniae; T activation; Thrombotic microangiopathies

Indexed keywords

PLANT LECTIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANAMNESIS; ARTICLE; BACTERIUM CULTURE; BLOOD SMEAR; CASE REPORT; CHILD; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COOMBS TEST; CORD SERUM; CREATININE BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMAGGLUTINATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; KIDNEY BIOPSY; NONHUMAN; PRESCHOOL CHILD; SEPSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA NITROGEN BLOOD LEVEL;

EID: 78650822601     PISSN: 11795557     EISSN: None     Source Type: Journal    
DOI: 10.4137/CPath.S670     Document Type: Article

References (20)

1. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolyticuraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1(8325):619-20.
2. Cleary TG, Lopez EL. The shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome. Pediatr Infect Dis J. 1989;8(10):720-4.
3. Milford DV, Taylor CM, Guttridge B, et al. Haemolytic uraemic syndromes in the British Isles 1985-8: Association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch of Dis Child. 1990;65(7):716-21.
4. Griffin PM, Mead PS, Sivapalasingam S. Escherischia coli 0157:H7 and other enterohemorrhagic In: Blaser MJ, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the Gastrointestinal Tract, 2nd ed. New York, NY: Lippincott Williams & Wilkins; 2002. p. 627-42.
5. Klein PJ, Bulla M, Newman RA, et al. Thomsen-Firiedenreich antigen in haemolytic-uraemic syndrome. Lancet. 1977;2(8046):1024-5.
6. Seger R, Joller P, Baerlocher K, et al. Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: Treatment by exchange transfusion. Helv Paediatr Acta. 1980;35(4):359-67.
7. Alon R, Adler S, Chan JCM. Hemolytic-uremic syndrome associated with Streptococcus pneumoniae. Am J Dis Child. 1984;138:496-9.
8. Seges R, Kenny A, Bird GWG, et al. Pediatric surgical patients with severe anaerobic infection: report of 16 T-antigen positive cases and possible hazards of blood transfusion. J Pediatr Surg. 1981;16(6):905-10.
9. Stewart CL, Tina LU. Hemolytic uremic syndrome. Pediatr Rev. 1993;14(6):218-24.
10. Erickson LC, Smith WS, Biswas AK, et al. Streptococcus pneumoniae-induced hemolytic uremic syndrome: A case for early diagnosis. Pediatr Nephrol. 1994;8(2):211-3.
11. McTaggart SJ, Burke JR. Streptococcus pneumoniae-induced haemolytic uraemic syndrome. J Paediatr Child Health. 1998;34(2):192-5.
12. Moulds JJ. Polyagglutination: Overview and resolution. In: Beck ML, Judd WJ, editors. Polyagglutination: A Technical Workshop, 1st ed. Washington DC. American Association of Blood Banks. 1980:1-22.
13. Judd WJ. Review: Polyagglutination. Immunohematol. 1992;8(3):58-67.
14. Beck ML. Tn: A non microbial form of polyagglutination. In: Beck ML, Judd WJ, editors. Polyagglutination: A Technical Workshop, 1st ed. Washington DC. American Association of Blood Banks. 1980:55-70.
15. Judd WJ. Microbial-associated forms of polyagglutination (T, Tk and Acquired B). In: Beck ML, Judd WJ, editors. Polyagglutination: A Technical Workshop, 1st ed. Washington DC. American Association of Blood Banks. 1980:23-53.
16. Crookston KP, Reiner AP, Cooper LJN, et al. RBC T activation and hemolysis: Implications for pediatric transfusion management. Transfusion. 2000;40:801-12.
17. Buskila D, Levene C, Bird GWG, Levene NA. Polyagglutination in hospitalized patients: A prospective study. Vox Sang. 1987;57:99-102.
18. Pisciotto PT, Luban NLC. Complications of neonatal transflusions. In: Popovsky MA, editor. Transfusion Reactions, 1st ed. Bethesda, MD. American Association of Blood Banks. 1996:321-56.
19. Boralessa H, Modi N, Cockburn H, et al. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Immunohematol. 2002;42:1428-34.
20. Eder AF, Manno CS. Does red-cell T activation matter? Brit J Haematol. 2001;114:25-30.